CD40 combination therapy can shrink pancreatic tumors
(University of Pennsylvania School of Medicine) A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Immunotherapy | Pancreas | Pancreatic Cancer | University of Pennsylvania